Access cutting-edge advanced solid tumors treatment through this clinical trial at a research site in Detroit. Study-provided care at no cost to qualified participants.
Access advanced solid tumors specialists in Detroit at no cost
This study follows strict safety protocols and ethical guidelines
All study-related advanced solid tumors treatment provided free
This is a phase 1, multicenter, nonrandomized, open-label, first-in-human study of YL201 conducted in China and the United States. The study will include 2 parts: a dose escalation part (Part 1) followed by a dose expansion part (Part 2). Part 1 will estimate the MTD/RED(s) in dose escalation cohorts of patients with advanced solid tumors unresponsive to currently available therapies or for whom no standard therapy is available. Part 2 will include patients with selected advanced solid tumor t
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Check if you qualify for this advanced solid tumors clinical trial in Detroit, MI
If you're searching for advanced solid tumors treatment options in Detroit, MI, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Detroit research site is actively enrolling participants for this clinical trial. You'll receive care from experienced advanced solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.